Article
Author(s):
As of 12/04/2001CDER, Warning and Untitled Letters for 2001, new and generic drug approvals, drug approval packages, and labeling updates.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.